Story thread · 2 reports / 2 sources
Roche succeeds in late-stage study for Lunsumio regimen in follicular lymphoma
seekingalpha.com · 6h · first report
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.